You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Discontinued Product(Pivaloyloxy)methyl butyrate (Cat. No. 0626) has been withdrawn from sale for commercial reasons.
Anti-neoplastic agent in vitro and in vivo, its mode of action possibly involving enzymatic release of butyric acid and formaldehyde in the cell.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Nudelman et al (1992) Novel anti-cancer prodrugs of butyric acid. 2. J.Med.Chem. 35 687 PMID: 1542095
View Related Products by Target
Keywords: (Pivaloyloxy)methyl butyrate, (Pivaloyloxy)methyl butyrate supplier, Miscellaneous, Compounds, 0626, Tocris Bioscience
Citations for (Pivaloyloxy)methyl butyrate
Citations are publications that use Tocris products.
Currently there are no citations for (Pivaloyloxy)methyl butyrate.
Reviews for (Pivaloyloxy)methyl butyrate
There are currently no reviews for this product. Be the first to review (Pivaloyloxy)methyl butyrate and earn rewards!
Have you used (Pivaloyloxy)methyl butyrate?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
New Product Guide [Spring/Summer 2019]
Our new product guide highlights over 215 new products added to the Tocris Bioscience range during the first half of 2019.
- 7-TM Receptors
- Enzyme-Linked Receptors
- Ion Channels
- Nuclear Receptors
- Fluorescent Imaging
- Signal Transduction
- Stem Cells